Narcolepsy clinical trials

Explore recruiting narcolepsy clinical trials.

Recruiting narcolepsy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Narcolepsy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV

Czechia, France, Belgium, Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy (Narcolepsy Type 1)

Norway, Spain, Germany, Netherlands, France, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Long-term Extension Trial to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions.

Norway, Finland, Germany, Italy, Spain, France +5 more

Phase II and Phase III (Integrated) EU CTIS Study details

An Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Durability of Treatment Effect of ALKS 2680 in Subjects With Narcolepsy Type 1 and Type 2 and Idiopathic Hypersomnia

Belgium, Netherlands, Czechia, Italy, France, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

Spain, Netherlands, Belgium, Italy, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy (Narcolepsy Type 1)

Denmark, Finland, France, Austria, Sweden, Czechia +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Narcolepsy trials by city

Narcolepsy in Toronto Narcolepsy in Vancouver Narcolepsy in Montreal Narcolepsy in Calgary Narcolepsy in Edmonton Narcolepsy in Ottawa Narcolepsy in Winnipeg Narcolepsy in Quebec City Narcolepsy in Hamilton Narcolepsy in Kitchener Narcolepsy in London Narcolepsy in Halifax Narcolepsy in New York Narcolepsy in Los Angeles Narcolepsy in Chicago Narcolepsy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease